Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANVS Annovis Bio, Inc.

休市中 08-23 16:00:00 EDT

9.69

+0.50

+5.44%

盘后9.69

+0.000.00%

19:30 EDT

最高9.98	最低9.22	成交量35.10万
今开9.25	昨收9.19	日振幅8.30%
总市值1.26亿	流通市值8,097万	总股本1,305万
成交额338.50万	换手率4.20%	流通股本835.65万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANVS","market":"US","secType":"STK","nameCN":"Annovis Bio, Inc.","latestPrice":9.69,"timestamp":1724443200000,"preClose":9.19,"halted":0,"volume":351010,"hourTrading":{"tag":"盘后","latestPrice":9.69,"preClose":9.69,"latestTime":"19:30 EDT","volume":630,"amount":6068.59,"timestamp":1724455815524},"delay":0,"floatShares":8356500,"shares":13054018,"eps":-5.260772,"marketStatus":"休市中","marketStatusCode":7,"change":0.5,"latestTime":"08-23 16:00:00 EDT","open":9.25,"high":9.9825,"low":9.22,"amount":3384983.88954,"amplitude":0.082971,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.260772,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1580274000000,"adjPreClose":9.19,"preHourTrading":{"tag":"盘前","latestPrice":9.19,"preClose":9.19,"latestTime":"08:35 EDT","volume":166,"amount":1519.6000219999999,"timestamp":1724416548001},"postHourTrading":{"tag":"盘后","latestPrice":9.69,"preClose":9.69,"latestTime":"19:30 EDT","volume":630,"amount":6068.59,"timestamp":1724455815524},"volumeRatio":1.5391368100171712,"impliedVol":1.056,"impliedVolPercentile":0.073},"requestUrl":"/m/hq/s/ANVS/tweets","defaultTab":"tweets","newsList":[{"id":"2460063893","title":"Annovis Bio, Inc.盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460063893","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460063893?lang=zh_cn&edition=full","pubTime":"2024-08-20 02:41","pubTimestamp":1724092861,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日02时41分，Annovis Bio, Inc.股票出现异动，股价快速上涨5.02%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002410197199308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002410197199308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2459204427","title":"Annovis Bio, Inc.盘中异动 早盘股价大涨6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459204427","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459204427?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:33","pubTimestamp":1723728821,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时33分，Annovis Bio, Inc.股票出现波动，股价快速拉升6.31%。截至发稿，该股报8.25美元/股，成交量1.4338万股，换手率0.13%，振幅2.13%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213341959ba0a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213341959ba0a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2458451297","title":"Annovis Bio Inc   预计每股亏损50美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458451297","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458451297?lang=zh_cn&edition=full","pubTime":"2024-08-10 01:59","pubTimestamp":1723226369,"startTime":"0","endTime":"0","summary":"   * Annovis Bio Inc    将于8月13日公布截至2024年6月30日的财报() 预计该公司的季度收入将保持不变。*    * LSEG 的分析师平均预计 Annovis Bio Inc 每股亏损 50 美分。* 目前分析师对该公司股票的平均评级为 \"买入\"，建议的细分为 3 个 \"强烈买入 \"或 \"买入\"，2 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Annovis Bio Inc 的 12 个月目标价中位数为 28.00 美元，高于其最新收盘价 8.25 美元。8月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Annovis Bio Inc   预计每股亏损50美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS"],"gpt_icon":0},{"id":"2458134725","title":"Annovis Bio, Inc.盘中异动 快速跳水5.09%报7.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458134725","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458134725?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:02","pubTimestamp":1723219336,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日00时02分，Annovis Bio, Inc.股票出现异动，股价急速下跌5.09%。截至发稿，该股报7.83美元/股，成交量10.5516万股，换手率0.94%，振幅7.06%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.08%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810000217aefe28ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810000217aefe28ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2457348597","title":"Annovis Bio, Inc.盘中异动 早盘大幅拉升5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457348597","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457348597?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:55","pubTimestamp":1723128910,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日22时55分，Annovis Bio, Inc.股票出现波动，股价大幅上涨5.55%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.63%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408082255109682532c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408082255109682532c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2457876781","title":"Annovis Bio, Inc.盘中异动 下午盘急速跳水5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457876781","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457876781?lang=zh_cn&edition=full","pubTime":"2024-08-08 03:23","pubTimestamp":1723058596,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日03时23分，Annovis Bio, Inc.股票出现波动，股价急速下挫5.69%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为2.44%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808032316af966d93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808032316af966d93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2457066028","title":"Annovis Bio, Inc.盘中异动 快速上涨5.04%报8.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457066028","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457066028?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:34","pubTimestamp":1722951267,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时34分，Annovis Bio, Inc.股票出现波动，股价大幅上涨5.04%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062134279582cd0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062134279582cd0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2457677397","title":"Annovis Bio, Inc.盘中异动 早盘股价大跌9.71%报7.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457677397","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457677397?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:42","pubTimestamp":1722865362,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时42分，Annovis Bio, Inc.股票出现异动，股价大幅跳水9.71%。截至发稿，该股报7.82美元/股，成交量5.1624万股，换手率0.46%，振幅2.94%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052142429f10760c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052142429f10760c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2457729835","title":"IBN宣布最新一期Bell2Bell播客节目特邀Annovis Bio首席执行官Maria Maccecchini博士在Aaic 2024直播。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457729835","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457729835?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:00","pubTimestamp":1722859203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4523","ANVS","BK4548","IE00BYTNYM70.SGD","LU0143863198.USD","LU1868837722.USD","SG9999004220.SGD","BK4139","BK4535","LU0823039010.USD","BK4585","BK4207","BK4588","IBN","LU0066902890.USD","IE00B0JY6M65.USD","LU1868838027.USD","LU1868837565.USD","LU0823038988.USD","LU1102505762.USD","LU0143863784.USD","LU0251143458.SGD","IE00B7N09G41.SGD"],"gpt_icon":0},{"id":"2456284435","title":"Annovis Bio, Inc.盘中异动 早盘快速下挫6.27%报8.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456284435","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456284435?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:38","pubTimestamp":1722605903,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时38分，Annovis Bio, Inc.股票出现波动，股价大幅下跌6.27%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Os Therapies Incorporated、Exicure, Inc.、Dermata Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为443.44%、426.64%、25.72%，振幅较大的相关个股有Os Therapies Incorporated、Exicure, Inc.、Dermata Therapeutics, Inc.，振幅分别为54.19%、38.17%、32.66%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213823aefcf908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213823aefcf908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"1124317986","title":"近期科技股剧烈起伏，CNBC点名以下成长股未来十年可以持有","url":"https://stock-news.laohu8.com/highlight/detail?id=1124317986","media":"老虎资讯综合","labels":["analysis"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124317986?lang=zh_cn&edition=full","pubTime":"2024-08-02 14:55","pubTimestamp":1722581734,"startTime":"0","endTime":"0","summary":"成长股最近波动很大，尤其是科技股，近几周经历了剧烈的起伏。他认为这两只股票适合长期持有十年。他指出，该公司目前正在研发治疗阿尔茨海默病和帕金森病的药物，所有的希望都寄托在试验的结果以及这些药物能否获得美国食品和药物管理局的批准上。他说，帕金森病药物的试验结果是混合的，但仅凭对药物的期望，这只股票已经大幅上涨。","market":"us","thumbnail":"https://static.tigerbbs.com/347452cc99fb488c45ccd900fcf3aa20","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/347452cc99fb488c45ccd900fcf3aa20"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TDG","WM","CASY","HEI","RSG","ANVS"],"gpt_icon":1},{"id":"2456433799","title":"Annovis Bio, Inc.盘中异动 股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456433799","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456433799?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:49","pubTimestamp":1722520146,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时49分，Annovis Bio, Inc.股票出现波动，股价快速拉升5.59%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Immuneering Corporation、Biomea Fusion, Inc.、Windtree Therapeutics, Inc.涨幅较大，Immuneering Corporation、Windtree Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为135.64%、94.83%、55.19%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Immuneering Corporation、Neurosense Therapeutics Ltd.，振幅分别为40.35%、29.20%、27.17%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801214906af9561a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801214906af9561a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2455134034","title":"Annovis Bio, Inc.盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455134034","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455134034?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:38","pubTimestamp":1722433115,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时38分，Annovis Bio, Inc.股票出现波动，股价快速下跌5.19%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731213835aefc7a06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731213835aefc7a06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2455518069","title":"Annovis Bio, Inc.盘中异动 快速下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455518069","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455518069?lang=zh_cn&edition=full","pubTime":"2024-07-30 22:50","pubTimestamp":1722351042,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日22时50分，Annovis Bio, Inc.股票出现波动，股价急速跳水5.39%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730225042aefc359a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730225042aefc359a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2454376281","title":"Annovis Bio, Inc.盘中异动 下午盘大幅上涨5.35%报11.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454376281","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454376281?lang=zh_cn&edition=full","pubTime":"2024-07-27 02:04","pubTimestamp":1722017087,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日02时04分，Annovis Bio, Inc.股票出现波动，股价大幅上涨5.35%。截至发稿，该股报11.03美元/股，成交量19.1773万股，换手率1.72%，振幅7.55%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727020447aefbb5ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727020447aefbb5ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2454748918","title":"Annovis Bio, Inc.盘中异动 早盘急速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454748918","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454748918?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:02","pubTimestamp":1721916168,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时02分，Annovis Bio, Inc.股票出现异动，股价急速跳水5.20%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725220248aefb777f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725220248aefb777f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2453885919","title":"Annovis Bio, Inc.盘中异动 早盘急速拉升5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453885919","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453885919?lang=zh_cn&edition=full","pubTime":"2024-07-24 22:02","pubTimestamp":1721829736,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日22时02分，Annovis Bio, Inc.股票出现异动，股价大幅上涨5.35%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724220216af93e86b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724220216af93e86b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2453795119","title":"Annovis Bio, Inc.盘中异动 早盘快速下跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453795119","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453795119?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:43","pubTimestamp":1721655788,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时43分，Annovis Bio, Inc.股票出现异动，股价快速跳水5.30%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722214308aefaca1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722214308aefaca1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2452406852","title":"Annovis Bio, Inc.盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452406852","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452406852?lang=zh_cn&edition=full","pubTime":"2024-07-20 00:24","pubTimestamp":1721406293,"startTime":"0","endTime":"0","summary":"北京时间2024年07月20日00时24分，Annovis Bio, Inc.股票出现波动，股价大幅下跌5.36%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720002453941f8da5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720002453941f8da5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2452381294","title":"Annovis Bio, Inc.盘中异动 早盘急速跳水5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452381294","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452381294?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:49","pubTimestamp":1721314185,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时49分，Annovis Bio, Inc.股票出现异动，股价快速跳水5.30%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718224945941f85b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718224945941f85b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annovisbio.com","stockEarnings":[{"period":"1week","weight":0.136},{"period":"1month","weight":-0.1003},{"period":"3month","weight":0.3292},{"period":"6month","weight":-0.0252},{"period":"1year","weight":-0.231},{"period":"ytd","weight":-0.4818}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annovis Bio, Inc.于2008年4月29日根据特拉华州法律注册成立。Annovis是一家临床阶段制药公司，专注于开发和商业化用于治疗帕金森氏症（“PD”）和阿尔茨海默氏症（“AD”）疾病以及其他神经退行性疾病的创新药物。该公司的先导化合物ANVS-401是一种神经化学神经缺陷疗法，可抑制神经变性并抑制神经毒性蛋白质转化为成人和正常化的轴突囊泡转运。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.001878},{"month":2,"riseRate":0.4,"avgChangeRate":0.208855},{"month":3,"riseRate":0.4,"avgChangeRate":-0.008916},{"month":4,"riseRate":0.2,"avgChangeRate":-0.160489},{"month":5,"riseRate":0.6,"avgChangeRate":0.247553},{"month":6,"riseRate":0.6,"avgChangeRate":0.216567},{"month":7,"riseRate":0.6,"avgChangeRate":0.066217},{"month":8,"riseRate":0.6,"avgChangeRate":-0.027237},{"month":9,"riseRate":0.5,"avgChangeRate":-0.049932},{"month":10,"riseRate":0,"avgChangeRate":-0.151029},{"month":11,"riseRate":0.75,"avgChangeRate":0.114437},{"month":12,"riseRate":0.5,"avgChangeRate":0.329002}],"exchange":"NYSE","name":"Annovis Bio, Inc.","nameEN":"Annovis Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annovis Bio, Inc.,ANVS,Annovis Bio, Inc.股票,Annovis Bio, Inc.股票老虎,Annovis Bio, Inc.股票老虎国际,Annovis Bio, Inc.行情,Annovis Bio, Inc.股票行情,Annovis Bio, Inc.股价,Annovis Bio, Inc.股市,Annovis Bio, Inc.股票价格,Annovis Bio, Inc.股票交易,Annovis Bio, Inc.股票购买,Annovis Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}